Method for sexing birds, birds, production method, and egg population

The SLC45A2 gene-based method allows for non-invasive sex determination of birds before hatching, addressing the issue of chick culling by enabling early sex identification in poultry farming.

JP2024162998AActive Publication Date: 2024-11-21SETSUROTECH INC
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
JP2024003097
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-01-12
Publication Date
2024-11-21
Estimated Expiration
2043-05-11

AI Technical Summary

Technical Problem

Current methods for sexing chickens are invasive and typically performed after hatching, leading to the unnecessary culling of male chicks, which is a global issue, especially in Europe where they must be culled by the seventh day after laying eggs.

Method used

A method is developed to determine the sex of birds based on the color of their eyes using the SLC45A2 gene, which is a loss-of-function pigment expression gene on the Z chromosome, allowing for sex differentiation before hatching by identifying heterozygous or homozygous gene expressions in avian eggs.

Benefits of technology

Enables non-invasive sex determination of birds before hatching, reducing the need for chick culling and improving efficiency in poultry farming by allowing for early sex identification.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024162998000001_ABST
    Figure 2024162998000001_ABST
Patent Text Reader

Abstract

To provide a method capable of sexing birds.SOLUTION: A method for sexing birds includes a step for sexing birds in a population of bird eggs on the basis of the eye color of each bird in the population of eggs. When the bird in the egg is male, the male bird has a loss-of-function pigment expression gene and a wild-type eye pigment expression gene in a heterozygous form for the eye pigment expression gene on the Z chromosome. When the bird in the egg is female, the female bird has a loss-of-function pigment expression gene for the eye pigment expression gene on the Z chromosome.SELECTED DRAWING: Figure 2
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to methods for sexing birds, birds, production methods, and egg populations. [Background technology]

[0002] For commercial use, chickens are sexed after hatching. After sexing, female chickens that lay eggs are delivered to egg-laying poultry farms, while male chickens that do not lay eggs are killed or otherwise disposed of. For this reason, the culling of male chickens has become a global problem (Non-Patent Document 1).

[0003] In Europe, chickens are required to be culled within 7 days after laying, when the nervous system is developed. Although efforts are being made to develop a technology to distinguish between males and females within 7 days after laying, no technology that does not use biomarkers or is non-invasive has yet been established. [Prior art documents] [Non-patent literature]

[0004] [Non-Patent Document 1] General Secretariat of the Council, “EU-wide end to the systematic killing of male chicks- Information from the French and German delegations on behalf of the Austrian, Belgian, Cyprus, Finnish, French, German, Irish, Luxembourg and Portuguese delegations”, [online], 12 October 2022, the Council ("Agriculture and Fisheries"), [Retrieved 11 May 2023], Internet<URL:https: / / data.consilium.europa.eu / doc / document / ST-13317-2022-INIT / x / pdf> Summary of the Invention [Problem to be solved by the invention]

[0005] Therefore, an object of the present disclosure is to provide a method for distinguishing between the sexes of birds. [Means for solving the problem]

[0006] In order to achieve the above object, the present disclosure provides a method for determining the sex of birds, comprising the steps of: determining the sex of birds in a population of eggs based on the eye color of each egg in the population of eggs; When the bird in the egg is a male bird, the male bird contains a heterozygous eye pigment expression gene and a wild-type eye pigment expression gene on the Z chromosome, If the bird in the egg is a female bird, the female bird comprises a loss-of-function eye pigment gene on the Z chromosome.

[0007] The birds disclosed herein have a loss of function for eye pigment expression genes on the Z chromosome.

[0008] The method for producing a bird of the present disclosure includes a step of mating a male bird with a female bird, the male bird is an avian of the present disclosure; The female bird is one which contains a wild-type eye pigment gene on the Z chromosome.

[0009] The population of avian eggs of the present disclosure is a population of avian eggs, comprising: When the bird in the egg is a male bird, the male bird contains a heterozygous eye pigment expression gene and a wild-type eye pigment expression gene on the Z chromosome, If the bird in the egg is a female bird, the female bird comprises a loss-of-function eye pigment gene on the Z chromosome. Effect of the Invention

[0010] According to the present disclosure, it is possible to distinguish between male and female birds. [Brief description of the drawings]

[0011]

Figure 1

Figure 2

Figure 3

[0012] <Definition> As used herein, "birds" refers to animals classified in the class Birds of the phylum Vertebrate.

[0013] As used herein, "loss of function" refers to, for example, a state in which the function originally possessed by a target gene is reduced or lost. The "loss of function" can also be referred to as, for example, inactivation.

[0014] As used herein, the term "loss of function mutation" refers to a mutation that significantly reduces the function of a gene of interest and / or a mutation that causes a complete loss of function. The "mutation that causes a complete loss of function" can also be referred to as, for example, a null mutation or an amorph.

[0015] As used herein, "avian" refers to an individual bird.

[0016] As used herein, "avian part" means a portion or part of an individual avian species.

[0017] As used herein, the term "eye pigment expression gene" refers to a gene that controls the expression of eye pigment. The eye pigment expression gene may also control the expression of pigment in tissues other than the eye.

[0018] As used herein, the term "sex chromosome" refers to a chromosome that has a different shape or number depending on the sex in an organism that has sexual differentiation. The sex chromosome in birds refers to the Z chromosome and / or the W chromosome.

[0019] As used herein, a "population" refers to two or more things gathered together as a single mass.

[0020] Sequence information of the proteins described herein or the nucleic acids (e.g., DNA or RNA) encoding them is available from Protein Data Bank, UniProt, Ensembl, GenBank, etc. Furthermore, the nucleic acid sequence of RNA can also be obtained from the nucleic acid sequence of the corresponding DNA using appropriate sequence conversion software or the like.

[0021] The present disclosure will be described below with examples, but the present disclosure is not limited to the following examples and can be modified as desired. In addition, each description in the present disclosure can be mutually incorporated unless otherwise specified. In this specification, when the expression "~" is used, it is used to mean including the numerical value or physical value before and after it. In this specification, the expression "A and / or B" includes "A only", "B only", and "both A and B".

[0022] <Birds> In one embodiment, the present disclosure provides a bird having a loss of function for an eye pigment expression gene on chromosome Z. The bird of the present disclosure has a loss of function for an eye pigment expression gene.

[0023] As a result of intensive research, the inventors came up with the idea that it may be possible to change the eye color of male and female birds by using the eye pigment expression gene on the sex chromosome. The inventors then discovered that the eye color of male and female birds can be changed by using the eye pigment expression gene on the Z chromosome, which is the sex chromosome of the bird, and that it is possible to discriminate between male and female birds based on this, and thus established the present invention. Specifically, it was found that the sex of progeny birds obtained by crossing a male bird that has the eye pigment expression gene homozygous and has lost function for the eye pigment expression gene with a female bird that has a wild-type eye pigment expression gene on the Z chromosome can be discriminated based on the eye color of the progeny birds. Generally, sex discrimination of birds is performed by anal discrimination or feather discrimination of birds, and these methods can be performed only after hatching. On the other hand, according to the present disclosure, it is also possible to distinguish the sex of birds before they hatch, and it is expected that it will be possible to distinguish the sex of birds by the time their nervous systems develop, for example, within seven days of incubation, using the date of egg-laying as the base date (day 0 of incubation).

[0024] Examples of the birds include birds of the Phasianidae family, Anatidae family, Ostrichidae family, Columbidae family, Guineafowl family, and Cassowary family. Examples of the birds of the Phasianidae family include chickens ( Gallusgallus domesticus ), quail ( Coturnix japonica ), turkey (Meleagris gallopavo), and pheasant ( Phasianus versicolor ) and the like. The birds of the Anatidae family include, for example, ducks ( Anas platyrhynchos var. domesticus), ducks (Anas), and geese ( Anser anser Examples of the birds of the Struthio family include the ostrich (Struthio camelus) and the like. Examples of the birds of the Columbidae family include the pigeon (Columbidae) and the like. Examples of the birds of the Guineafowl family include the guinea fowl (Numida meleagris) and the like. Examples of the birds of the Cassowary family include the emu (Dromaius novaehollandiae) and the like. Examples of the chicken breeds include the White Leghorn, Brown Leghorn, Barred Rock, Sussex, New Hampshire, Rhode Island, Ausstralorp, Minorca, Amrox, California Gray, Italian Partidge colored, and Korean Oge and the like.

[0025] In the present disclosure, the bird may be a fixed species or a hybrid, for example, a hybrid resulting from intergeneric or interspecific crossing.

[0026] In the present disclosure, the bird is preferably, for example, a livestock bird or poultry.

[0027] In the present disclosure, the eye pigment expression gene is not particularly limited as long as it is a gene capable of controlling the expression of eye pigment. The expression control can be, for example, induction, promotion, or enhancement of the expression or function of a target gene or a protein encoded by the gene, or suppression, reduction, or termination of the expression or function of a target gene or the target gene or a protein encoded by the gene.

[0028] In the present disclosure, the eye pigment expression gene on the Z chromosome (hereinafter also referred to as "eye pigment expression gene") may be, for example, the SLC45A2 (Solute carrier family 45 member 2) gene. The SLC45A2 gene has, for example, a function of inducing, promoting, or enhancing the expression of the eye pigment. The eye pigment is, for example, eumelanin and / or pheomelanin.

[0029] The SLC45A2 is generally known as a proton-associated glucose and sucrose transporter. It is presumed that the SLC45A2 gene maintains the osmotic pressure in the melanosome by transporting glucose and sucrose, and maintains the pH in the melanosome, thereby promoting the conversion of inactive tyrosinase to active tyrosinase by binding with copper ions. In the present disclosure, examples of the chicken SLC45A2 gene include, for example, a polynucleotide consisting of the base sequence registered in Genbank under accession number NM_001083364.3 as mRNA, and a polypeptide consisting of the amino acid sequence registered under accession number NP_001076833.3 as protein.

[0030] As a specific example, the chicken SLC45A2 gene (wild-type SLC45A2 gene) may be, for example, the polynucleotide (S) below or a genomic region encoding the same. The nucleotide sequence of SEQ ID NO: 1 below is a nucleotide sequence including a stop codon.

[0031] (S) any one of the following polynucleotides (S1) to (S7): (S1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1; (S2) a polynucleotide encoding a protein having the function of expressing eye pigment, the polynucleotide consisting of the base sequence of (S1) in which one or several bases have been deleted, substituted, inserted, and / or added; (S3) a polynucleotide having a base sequence having 80% or more identity to the base sequence of (S1), and encoding a protein having a function of expressing eye pigment; (S4) a polynucleotide having a nucleotide sequence complementary to a polynucleotide that hybridizes under stringent conditions to the polynucleotide having the nucleotide sequence of (S1), and encoding a protein having the function of expressing eye pigment; (S5) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2; (S6) a polynucleotide encoding a protein having the function of expressing eye pigment, comprising an amino acid sequence in which one or several amino acids are deleted, substituted, inserted, and / or added in the amino acid sequence of SEQ ID NO: 2; (S7) A polynucleotide that consists of an amino acid sequence having 80% or more identity to the amino acid sequence of SEQ ID NO:2 and encodes a protein having the function of expressing eye pigment.

[0032] Nucleotide sequence of chicken SLC45A2 gene (SEQ ID NO: 1)

[0033] In the above (S1), the base sequence of SEQ ID NO: 1 is a base sequence that encodes the amino acid sequence (SEQ ID NO: 2) in the above (S5). Gallus gallus domesticus ) can be obtained.

[0034] In (S2), "one or several" may be, for example, within a range in which the protein encoded by the polynucleotide of (S2) has the function of expressing eye pigments. The function of expressing eye pigments means, for example, a function capable of inducing, promoting, or enhancing the expression of the eye pigments (hereinafter the same). "One or several" in (S2) means, for example, 1 to 326, 1 to 244, 1 to 163, 1 to 81, 1 to 65, 1 to 48, 1 to 32, 1 to 16, 1 to 8, 1 to 5, 1 to 3, 1 or 2, or 1 in the base sequence of (S1). In the present disclosure, the numerical range of the number of bases or amino acids, for example, discloses all positive integers that fall within that range. That is, for example, the description "1 to 5" means the disclosure of all of "1, 2, 3, 4, and 5" (hereinafter the same).

[0035] In (S3), the "identity" may be within a range in which the protein encoded by the polynucleotide of (S3) has the function of expressing eye pigment. The identity of (S3) is, for example, 80% or more, 85% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more with respect to the base sequence of (S1). The "identity" can be determined by aligning two base sequences or amino acid sequences (hereinafter the same). The alignment can be calculated using, for example, BLAST, FASTA, or the like with default parameters.

[0036] In the above (S4), the "hybridizing polynucleotide" may be any polynucleotide that is capable of expressing eye pigments, so long as the protein encoded by the polynucleotide of (S4) has the function of expressing eye pigments. In the above (S4), the "hybridizing polynucleotide" is, for example, a polynucleotide that is completely or partially complementary to the polynucleotide of (S1). The hybridization can be detected, for example, by various hybridization assays. The hybridization assay is not particularly limited, and may be, for example, a hybridization assay such as that described in "Molecular Cloning: A Laboratory Manual 2nd Edition" edited by Sambrook et al. nd Alternatively, the method described in, for example, "Cold Spring Harbor Laboratory Press (1989)" can be adopted.

[0037] In the above (S4), the "stringent conditions" may be, for example, low stringency conditions, medium stringency conditions, or high stringency conditions. The "low stringency conditions" are, for example, 5×SSC, 5×Denhardt's solution, 0.5% SDS, 50% formamide, and 32° C. The "medium stringency conditions" are, for example, 5×SSC, 5×Denhardt's solution, 0.5% SDS, 50% formamide, and 42° C. The "high stringency conditions" are, for example, 5×SSC, 5×Denhardt's solution, 0.5% SDS, 50% formamide, and 50° C. Those skilled in the art can set the degree of stringency by appropriately selecting conditions such as temperature, salt concentration, probe concentration and length, ionic strength, and time. The "stringent conditions" are, for example, those described in the aforementioned "Molecular Cloning: A Laboratory Manual 2nd Edition" edited by Sambrook et al. nd Alternatively, the conditions described in, for example, "Cold Spring Harbor Laboratory Press (1989)" Ed. may be employed.

[0038] The polynucleotide (S5) may be, for example, a base sequence that allows the protein encoded by the polynucleotide (S5) to express eye pigments. The base sequence of the polynucleotide (S5) can be designed, for example, by substituting the corresponding codons based on the amino acid sequence of SEQ ID NO: 2.

[0039] Amino acid sequence of chicken SLC45A2 protein (SEQ ID NO:2) MTLTEQHFQESPPPPSEVAKADMDSTGGKEKAAQPSTARTGALVRKQQATGRLIMHSMAMFGREFCYAVEAAFVTPVLLSVGLPKSLYSLVWLISPILGFVLQPVVGSASDHCACSWGRRRPYILGLGIIMLVGM ALYLNGDEMISAFIGEREKQRTWAIVITMLGVVLFDFAADFIDGPIKAYLFDVCSHEDKEKGLHYHALFTGLGGALGYLTGAVDWGETVLGYSLTSEFQVIFLLSALVFLICLIVHLRSIPEVPLRYGNKETKLLL EVTEPYKYRSIEEIKNGYSSCTDLNATSKTKKGTDASCSEAQRRMTLKSLLKTLLSMPSHYRCLCVSHLFGWMAFMSNMLFFTDFMGQVVYQGSPYASHNSTLYHTYRRGVEVGCWGLCINAIASSAYSYLQKVLL PYIGLKGLYFIGYLLFGLGTGLIGLFPNVYSTLVLCSLFGVMSSTLYTVPFQLIAEYHKEEEDLNLQQKEQGTEHGRGKGIDCAALTCMVQLAQIILGVGLGLLVSVAGSAVTVISASMVALIGCCFVAFCVRYVG

[0040] In (S6), the "one or several" in the amino acid sequence may be within a range in which the protein encoded by the polynucleotide of (S6) has the function of expressing eye pigment. The "one or several" in (S6) may be, for example, 1 to 108, 1 to 81, 1 to 54, 1 to 27, 1 to 21, 1 to 16, 1 to 10, 1 to 5, 1 to 3, 1 or 2, or 1 in the amino acid sequence of SEQ ID NO: 2.

[0041] In the above (S7), the "identity" of the amino acid sequence may be within a range in which the protein encoded by the polynucleotide of the above (S7) has the function of expressing eye pigments. The identity of the above (S7) is, for example, 80% or more, 85% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more with respect to the amino acid sequence of SEQ ID NO:2.

[0042] In the present disclosure, the "eye pigment expression function" can be evaluated, for example, by directly or indirectly confirming the eye pigment of the target bird (subject bird). The direct confirmation can be performed, for example, by visually or optically evaluating the expression of the eye pigment of the subject bird. The indirect confirmation can be evaluated, for example, based on the expression of an eye pigment expression gene or an eye pigment expression protein in a biological sample of the subject bird. The biological sample of the subject bird is not particularly limited, and may be, for example, either an individual bird of the subject bird or a part of the individual bird, and is preferably an eye, feather, or the like of a bird. When the biological sample of the subject bird is feather, it is preferable that the subject bird is a bird of a lineage that expresses pigment in feathers in the wild type. The type of biological sample used may be, for example, one type, or two or more types.

[0043] When the eye pigment of the subject bird is evaluated visually or optically, the expression function of the eye pigment can be evaluated by, for example, evaluating the eye color of the subject bird after the development of the eye based on the eye color of a bird having a wild-type eye pigment expression gene or a bird having a function-loss form of the eye pigment expression gene. Specifically, in accordance with Example 1 described below, the eye color of the subject bird is visually observed after the development of the eye, or the eye color of the bird in the egg is measured by absorbance using an egg inspection device or the like. When the eye pigment of the subject bird is the same phenotype as that of a male bird having the wild-type eye pigment gene on the Z chromosome in a homozygous or heterozygous form, and / or a female bird having the wild-type eye pigment gene on the Z chromosome, the subject bird can be evaluated as having, for example, an eye pigment expression function. On the other hand, when the eye pigment of the test bird is the same phenotype as that of a male bird having a homozygous loss-of-function of the eye pigment gene on the Z chromosome and / or a female bird having a loss-of-function of the eye pigment gene on the Z chromosome, the test bird can be evaluated as having no eye pigment expression function, for example. When the bird is a chicken, the time of eye development is, for example, about 50 hours (about 3 days) after incubation, and the time of eye pigment expression is, for example, about 72 hours (about 3 to 4 days) after incubation (Reference 1). Therefore, when the bird is a chicken, the expression function of the eye pigment can be evaluated based on the eye pigment after 3 days or 4 days of incubation, preferably after 4 days of incubation. Reference 1: Hamburger V, Hamilton HL. A series of normal stages in the development of the chick embryo. 1951. Dev Dyn. 1992 Dec;195(4):231-72. doi: 10.1002 / aja.1001950404. PMID: 1304821.

[0044] When the evaluation is based on the expression of the eye pigment expression gene, the expression of the eye pigment expression gene can be performed, for example, by detecting the expression of the mRNA of the eye pigment expression gene. Extraction of mRNA from the biological sample of the subject bird can be performed by a conventional method. Detection of the expression of the mRNA of the eye pigment expression gene can be performed, for example, by semi-quantitative PCR, quantitative PCR, northern blotting, digital PCR, RNA sequence analysis (RNAseq), etc. Primers and / or probes used to detect the expression of the mRNA can be designed, for example, by a general method in this technical field. The test bird can be evaluated as having, for example, eye pigment expression function if the expression level of the eye pigment expression gene in the biological sample from the test bird is the same (no significant difference) as the expression level of the eye pigment expression gene in male birds having the wild-type eye pigment gene on the Z chromosome in a homozygous or heterozygous form and / or in female birds having the wild-type eye pigment gene on the Z chromosome; if the expression level of the eye pigment expression gene in the biological sample from the test bird is (significantly) higher than the expression level of the eye pigment expression gene in male birds having the wild-type eye pigment gene on the Z chromosome in a homozygous or heterozygous form and / or in female birds having the wild-type eye pigment gene on the Z chromosome; and / or if the expression level of the eye pigment expression gene in the biological sample from the test bird is (significantly) higher than the expression level of the eye pigment expression gene in male birds having a homozygous form of the loss-of-function form of the eye pigment gene on the Z chromosome and / or in female birds having a loss-of-function form of the eye pigment gene on the Z chromosome.On the other hand, if the expression level of the eye pigment expression gene in the biological sample of the test bird is (significantly) lower than the expression level of the eye pigment expression gene in male birds having the wild-type eye pigment gene on the Z chromosome in a homozygous or heterozygous form and / or in female birds having the wild-type eye pigment gene on the Z chromosome, if the expression level of the eye pigment expression gene in the biological sample of the test bird is the same (not significantly different) as the expression level of the eye pigment expression gene in male birds having a homozygous loss-of-function form of the eye pigment gene on the Z chromosome and / or in female birds having a loss-of-function form of the eye pigment gene on the Z chromosome, or if the expression level of the eye pigment expression gene in the biological sample of the test bird is lower than the expression level of the eye pigment expression gene in male birds having a homozygous loss-of-function form of the eye pigment gene on the Z chromosome and / or in female birds having a loss-of-function form of the eye pigment gene on the Z chromosome, the test bird can be evaluated as not having eye pigment expression function, for example.

[0045] When the evaluation is based on the expression of the eye pigment-expressing protein, the expression of the eye pigment-expressing protein can be detected by, for example, an ultraviolet absorption method, a method using a spectrophotometer such as the bicinchoninic acid method, ELISA, Western blotting, etc. The preparation of an extract containing the protein from the bird can be carried out by a general method in this technical field, such as ultrasonic disruption or physical disruption using a homogenizer. If the expression level of the eye pigment expression protein in the biological sample of the test bird is the same (no significant difference) as the expression level of the eye pigment expression gene protein in male birds having the wild-type eye pigment gene on the Z chromosome in a homozygous or heterozygous form and / or in female birds having the wild-type eye pigment gene on the Z chromosome, if the expression level of the eye pigment expression protein in the biological sample of the test bird is (significantly) higher than the expression level of the eye pigment expression protein in male birds having the wild-type eye pigment gene on the Z chromosome in a homozygous or heterozygous form and / or in female birds having the wild-type eye pigment gene on the Z chromosome, and / or if the expression level of the eye pigment expression protein in the biological sample of the test bird is (significantly) higher than the expression level of the eye pigment expression protein in male birds having a homozygous loss-of-function form of the eye pigment gene on the Z chromosome and / or in female birds having a loss-of-function form of the eye pigment gene on the Z chromosome, the test bird can be evaluated as having, for example, eye pigment expression function.On the other hand, if the expression level of the eye pigment expression protein in the biological sample of the test bird is (significantly) lower than the expression level of the eye pigment expression protein in male birds having the wild-type eye pigment gene on the Z chromosome in a homozygous or heterozygous form and / or in female birds having the wild-type eye pigment gene on the Z chromosome, if the expression level of the eye pigment expression protein in the biological sample of the test bird is the same (not significantly different) as the expression level of the eye pigment expression protein in male birds having a homozygous loss-of-function form of the eye pigment gene on the Z chromosome and / or in female birds having a loss-of-function form of the eye pigment gene on the Z chromosome, or if the expression level of the eye pigment expression protein in the biological sample of the test bird is lower than the expression level of the eye pigment expression protein in male birds having a homozygous loss-of-function form of the eye pigment gene on the Z chromosome and / or in female birds having a loss-of-function form of the eye pigment gene on the Z chromosome, the test bird can be evaluated as not having eye pigment expression function, for example.

[0046] In the present disclosure, the eye pigment expression gene may be in the form of RNA (e.g., mRNA) or DNA (e.g., cDNA or genomic DNA). The DNA may be double-stranded or single-stranded. In the present disclosure, the gene may include additional sequences, such as sequences of untranslated regions (UTRs).

[0047] The loss of function of the eye pigment expression gene means a state in which the function of the eye pigment expression gene is (significantly) reduced or lost to the extent that a bird having a loss-of-function form of the eye pigment expression gene loses eye pigment expression function compared to a bird having a wild-type eye pigment expression gene (hereinafter also referred to as "wild-type bird"). Specifically, the loss of function of the eye pigment expression gene may mean, for example, a state in which the expression level of the mRNA of the eye pigment expression gene or the protein encoded by the gene is (significantly) reduced, or a state in which the mRNA of the eye pigment expression gene or the protein encoded by the gene is not fully expressed, or a state in which the expression level of the functional mRNA of the eye pigment expression gene or the protein encoded by the eye pigment expression gene is reduced, or a state in which the mRNA of the functional eye pigment expression gene or the protein encoded by the eye pigment expression gene is not fully expressed. For this reason, in the present disclosure, the loss of function of the eye pigment expression gene may be carried out by introducing a loss-of-function mutation into the eye pigment expression gene, or by introducing a polynucleotide that suppresses the expression of the eye pigment expression gene. The above-mentioned "suppression of gene expression" may mean suppression of gene transcription or suppression of translation into protein.

[0048] In the present disclosure, the bird in which the eye pigment expression gene has lost its function can be said to be, for example, a bird having a function-loss form of the eye pigment expression gene. Generally, in the case of male birds, the Z chromosome is homozygous as a sex chromosome, and in the case of female birds, the Z chromosome and the W chromosome are heterozygous as sex chromosomes. The bird in the present disclosure has, for example, the eye pigment expression gene on the Z chromosome. In addition, the loss of eye pigment expression in birds obtained by the loss of function of the eye pigment expression gene is, for example, a recessive (recessive) trait. For this reason, in the bird in the present disclosure, for example, in males, the eye pigment expression gene on either one of the Z chromosomes among the eye pigment expression genes on the Z chromosome may be lost, but it is preferable that the eye pigment expression genes on both Z chromosomes are lost. In addition, in the bird in the present disclosure, for example, the eye pigment expression gene on the Z chromosome may be lost. In the bird in which the eye pigment expression gene has lost its function, genes other than the eye pigment expression gene may be further modified, altered, introduced, and / or lost.

[0049] The loss of function of the eye pigment expression gene can be caused, for example, by introducing a mutation, more specifically, a loss-of-function mutation, into the eye pigment expression gene. The type of the mutation is not particularly limited, and examples thereof include point mutations, splice mutations, missense mutations, nonsense mutations, frameshift mutations, and deletion of bases over a wide range (large deletion). The mutation may cause, for example, a partial or complete deletion of the eye pigment expression gene. The frameshift mutation is a mutation that occurs when a deletion or insertion of a base occurs, causing a shift in the triplet reading frame (codon). The frameshift mutation has a much greater effect on gene function than a mutation caused by base pair substitution. This is because when the frameshift mutation occurs, the genetic code after the point where the frameshift mutation is introduced in the gene is significantly shifted, and not only the amino acid changes, but also the stop codon and the like are shifted.

[0050] The loss-of-function form of the eye pigment expression gene is, for example, a gene in which one or several bases (hereinafter also referred to as "one or more bases") have been mutated, such as deleted, substituted, inserted and / or added, relative to the base sequence of the wild-type eye pigment expression gene. The one or more bases can be, for example, the explanation of the number of bases in the above explanation of (S2) in the base sequence of the eye pigment expression gene. The frameshift mutation occurs, for example, by the insertion or deletion of 3m+1 bases or 3m+2 bases (m is an integer of 0 or more). For example, the loss-of-function form of the eye pigment expression gene suppresses the expression function of eye pigments.

[0051] In the present disclosure, the mutation in the eye pigment expression gene can be induced, for example, by introducing a mutation into a target gene in the genome of a target bird by a conventional method. The target for introducing the mutation can be, for example, a bird cell, and specific examples thereof include primordial germ cells and embryonic stem cells (ES cells). The method for introducing the mutation can be, for example, homologous recombination; genome editing techniques using ZFN, TALEN, CRISPR-CAS9, CRISPR-CPF1, etc.; etc. The method for introducing the mutation can be, for example, a mutation introduction method such as a site-directed mutagenesis method. The method for introducing the mutation can also be, for example, a random mutagenesis method. The random mutagenesis method can be, for example, radiation irradiation treatment with α rays, β rays, γ rays, X-rays, etc.; chemical treatment with mutagens such as ethyl methanesulfonate (EMS) and ethynylnitrosourea (ENU); heavy ion beam treatment; and the like. The method for introducing a mutation using the genome editing technology can be carried out, for example, by referring to Example 1 described below, using the method described in Japanese Patent No. 7113415. Specifically, the introduction of a mutation using the genome editing technology can be carried out, for example, by introducing a protein and a nucleic acid constituting the genome editing technology, or a vector encoding these. The protein can be, for example, a CRISPR (Clustered Regularly Interspaced Short Palindromic Specific examples of such enzymes include Cas1, Cas1B, Cas2, Cas3, Cas4, Cas5, Cas6, Cas7, Cas8, Cas9, Cas10, Csy1, Csy2, Csy3, Cse1, Cse2, Csc1, Csc2, Csa5, Csn2, Csm2, Csm3, Csm4, Csm5, Csm6, Cmr1, Cmr3, Cmr4, Cmr5, Cmr6, Csb1, Csb2, Csb3, Csx17, Csx14, Csx10, Csx16, CsaX, Csx3, Csx1, Csx15, Csf1, Csf2, Csf3, and Csf4. The protein may also be, for example, an artificially designed nuclease based on the CRISPR enzyme.Examples of the nuclease include MAD7 and mutant MAD7 (for example, Japanese Patent Publication No. 7113415). Examples of the nucleic acid include crRNA and, optionally, tracrRNA, or a single-stranded nucleic acid in which these are linked via a linker. In this case, the nucleic acid is designed such that, for example, a base sequence that anneals to a target sequence in crRNA is complementary to a base sequence that encodes an eye pigment expression gene. The nucleic acid may be used alone or in combination with two or more types. When the genome editing technology is used, for example, by using two or more types of nucleic acid, large deletion of the base sequence between the target sequences can be induced, and for example, the entire target gene can be deleted. The method for introducing the mutation may be carried out by a mutation introduction method such as site-directed mutagenesis.

[0052] The position of the mutation in the loss-of-function of the eye pigment expression gene, i.e., the position where the mutation is introduced into the eye pigment expression gene, is not particularly limited and can be set to any region related to the eye pigment expression gene. Specific examples of the position of the mutation in the loss-of-function of the eye pigment expression gene include, for example, an expression control region such as a promoter region of the eye pigment expression gene, an exon region including a coding region that codes for a protein encoded by the eye pigment expression gene, and a non-coding region (e.g., an intron region, an enhancer region, etc.) that does not code for a protein encoded by the eye pigment expression gene, and is preferably an exon region. Examples of the exon region include the first exon and the second exon.

[0053] As a specific example, when the bird is a chicken and the eye pigment expression gene is the SLC45A2 gene, the position of the mutation in the SLC45A2 gene can be, for example, the 545th to 615th bases (SEQ ID NO: 3) in the base sequence of SEQ ID NO: 1. The position of the mutation in the SLC45A2 gene is, for example, a position corresponding to the second exon of the chicken SLC45A2 gene. The mutation introduced at these positions of mutation is preferably a frameshift mutation or a splice mutation.

[0054] Nucleotide sequence of the mutation site in the chicken SLC45A2 gene (SEQ ID NO: 3) 5'-AAGCATATTTATTTGACGTCTGCTCTCATGAAGATAAAGAGAAGGGTCTGCATTATCATGCCCTGTTTACA-3'

[0055] Examples of the loss-of-function form of the avian SLC45A2 gene include the following polynucleotides (M) and (T), or genomic regions encoding these polynucleotides:

[0056] (M) any one of the following polynucleotides (M1) to (M7): (M1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1; (M2) a polynucleotide encoding a protein with suppressed expression function of eye pigment, the polynucleotide consisting of a base sequence in which one or several bases are deleted, substituted, inserted, and / or added in the base sequence of (M1); (M3) a polynucleotide having a base sequence having 80% or more identity to the base sequence of (M1), encoding a protein having a suppressed eye pigment expression function; (M4) a polynucleotide having a nucleotide sequence complementary to a polynucleotide that hybridizes under stringent conditions to a polynucleotide having the nucleotide sequence of (M1), and encoding a protein in which the expression function of eye pigment is suppressed; (M5) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2; (M6) a polynucleotide encoding a protein having an amino acid sequence in which one or several amino acids are deleted, substituted, inserted, and / or added in the amino acid sequence of SEQ ID NO:2 and in which the expression function of eye pigment is suppressed; (M7) A polynucleotide encoding a protein having an amino acid sequence having 80% or more identity to the amino acid sequence of SEQ ID NO:2, the protein having a suppressed eye pigment expression function.

[0057] In the polynucleotides (M1) to (M7), "the expression function of eye pigments is suppressed" means, for example, that the expression function of eye pigments is significantly suppressed compared to the protein encoded by the polynucleotide (S1) or (S5), and preferably means that the expression function of eye pigments is completely lost.

[0058] The "one or several" in (M2) means, for example, 1 to 326, 1 to 244, 1 to 163, 1 to 81, 1 to 65, 1 to 48, 1 to 32, 1 to 16, 1 to 8, 1 to 5, 1 to 3, 1 or 2, or 1 in the base sequence of SEQ ID NO: 1.

[0059] The identity of (M3) to the base sequence of SEQ ID NO:1 is, for example, 80% or more, 85% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more.

[0060] In (M4), the "hybridizing polynucleotide" is, for example, a polynucleotide that is completely or partially complementary to the polynucleotide consisting of the base sequence of SEQ ID NO: 1. The hybridization can be detected, for example, by various hybridization assays. In (M4), the hybridization and stringent conditions can be as described in (S4).

[0061] The "one or several" in (M6) means, for example, 1 to 108, 1 to 81, 1 to 54, 1 to 27, 1 to 21, 1 to 16, 1 to 10, 1 to 5, 1 to 3, 1 or 2, or 1 in the amino acid sequence of SEQ ID NO: 2.

[0062] The identity of (M7) to the amino acid sequence of SEQ ID NO:2 is, for example, 80% or more, 85% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more.

[0063] (T) any one of the following polynucleotides (T1) to (T4): (T1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1 in which the 545th to 615th nucleotides are deleted; (T2) a polynucleotide encoding a protein with suppressed expression function of eye pigment, the polynucleotide comprising a base sequence in which one or several bases have been deleted, substituted, inserted, and / or added in the base sequence of the polynucleotide of (T1); (T3) a polynucleotide having a base sequence having 80% or more identity to the base sequence of the polynucleotide of (T1), encoding a protein having a suppressed function of expressing eye pigment; (T4) A polynucleotide having a base sequence complementary to a polynucleotide that hybridizes under stringent conditions to a polynucleotide having the base sequence of (T1), and encoding a protein whose eye pigment expression function is suppressed.

[0064] In the polynucleotides (T1) to (T4), "the expression function of eye pigments is suppressed" means, for example, that the expression function of eye pigments is significantly suppressed compared to the protein encoded by the polynucleotide (S1) or (S5), and preferably means that the expression function of eye pigments is completely lost.

[0065] The "one or several" in (T2) means, for example, 1 to 312, 1 to 234, 1 to 156, 1 to 78, 1 to 62, 1 to 46, 1 to 31, 1 to 15, 1 to 7, 1 to 5, 1 to 3, 1 or 2, or 1 in the base sequence of (T1).

[0066] The identity of (T3) to the base sequence of (T1) is, for example, 80% or more, 85% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more.

[0067] In (T4), the "hybridizing polynucleotide" is, for example, a polynucleotide that is completely or partially complementary to the polynucleotide consisting of the base sequence of (T1). The hybridization can be detected, for example, by various hybridization assays. In (T4), the hybridization and stringent conditions can be as described in (S4).

[0068] In the present disclosure, when the function of the eye pigment expression gene is lost by suppressing the expression of the eye pigment expression gene, the loss of function of the eye pigment expression gene can be achieved, for example, by introducing a polynucleotide that suppresses the expression of the eye pigment expression gene into a target bird. The method of introducing the polynucleotide is not particularly limited, and can be carried out by, for example, RNA interference, antisense RNA, genome editing technology, etc. An expression cassette such as an expression vector containing the polynucleotide can be introduced into a target bird by, for example, microinjection, polyethylene glycol method, electroporation method, particle gun method, etc. The target bird may be, for example, any of eggs, chicks, young birds, juvenile birds, and adult birds.

[0069] As described above, the birds of the present disclosure are obtained by the occurrence of a loss-of-function mutation in a wild-type eye pigment expression gene. Therefore, the birds of the present disclosure can also be referred to as, for example, "bird mutants". Furthermore, the birds of the present disclosure may be descendants of "bird mutants" and may be birds having a loss-of-function mutation in the eye pigment expression gene. The birds of the present disclosure can also be referred to as, for example, bird mutants having a genetic mutation introduced into the base sequence of the eye pigment expression gene by the above-described method for introducing a mutation. The birds of the present disclosure exclude, for example, birds obtained solely by means of an essentially biological process.

[0070] The method for producing birds according to the present disclosure can be referenced in the description of the production method described below.

[0071] <Bird part> In another aspect, the present disclosure provides a portion of an avian having a loss of function for an eye pigment expression gene on the Z chromosome. The avian portion of the present disclosure is the avian portion of the present disclosure.

[0072] The bird part may be, for example, an edible part of the bird, such as muscle, skin, heart, liver, gizzard, bone, and cartilage.

[0073] In another embodiment, the present disclosure provides a population of avian eggs. The population of eggs of the present disclosure is a population of avian eggs, and when the bird in the egg is a male bird, the male bird has a heterozygous eye pigment expression gene with a loss of function and a wild-type eye pigment expression gene for the eye pigment expression gene on the Z chromosome, and when the bird in the egg is a female bird, the female bird has a heterozygous eye pigment expression gene with a loss of function for the eye pigment expression gene on the Z chromosome. The description of the bird in the present disclosure can be used for the population of avian eggs of the present disclosure.

[0074] The population of avian eggs according to the present disclosure can be suitably used, for example, in the method for determining the sex of birds described below. Therefore, the population of avian eggs according to the present disclosure can also be referred to as, for example, a population of avian eggs for use in determining the sex of birds.

[0075] In the bird egg group of the present disclosure, the number of eggs may be 2 or more, and the upper limit is not particularly limited. The number of eggs in the egg group is, for example, 10 to 10 million, 10 to 1 million, or 100 to 100,000. The number of eggs in the egg group can be adjusted according to the scale of, for example, a breeding chicken farm.

[0076] The group of avian eggs of the present disclosure is, for example, fertilized eggs. In the group of avian eggs, each egg is, for example, an egg containing an embryo. The group of avian eggs is, for example, a group including eggs that have been incubated for 0 to 10 days, 0 to 7 days, 3 to 7 days, 4 to 7 days, 5 to 7 days, or 6 to 7 days, based on the day of laying (incubation day 0). The fertilized eggs may be obtained by, for example, candling using an egg candling machine or the like to remove infertile eggs and developmentally aborted eggs. The candling is preferably performed, for example, on the 5th or 6th day of incubation.

[0077] The population of avian eggs of the present disclosure may be contained in a material or container, such as, for example, egg materials, such as plastic cartons, setter trays, trays, etc.; shipping materials, such as containers, etc.

[0078] <Discrimination method> In another aspect, the present disclosure provides a method for determining the sex of a bird using the bird of the present disclosure. The method for determining the sex of a bird of the present disclosure includes a step of determining the sex of a bird based on the eye color of each egg of the bird in a group of eggs. When the bird in the egg is a male bird, the male bird contains a heterozygous eye pigment expression gene with a loss of function and a wild-type eye pigment expression gene for the eye pigment expression gene on the Z chromosome, and when the bird in the egg is a female bird, the female bird contains a heterozygous eye pigment expression gene with a loss of function for the eye pigment expression gene on the Z chromosome. The description of the bird of the present disclosure can be used for the method of determination of the present disclosure.

[0079] The discrimination method of the present disclosure may include a step (preparation step) of mating male parent birds with female parent birds to prepare the population of eggs prior to the discrimination. The male parent birds have lost function of the eye pigment expression gene and contain the lost-function pigment expression gene in a homozygous state. The female parent birds contain a wild-type eye pigment expression gene for the eye pigment expression gene. The preparation step can also be referred to as the mating step, for example. The explanation of the mating step in the production method described below can be applied to the mating step.

[0080] As described above, the discrimination step of the present disclosure discriminates the sex of the bird based on the eye color of the bird of each egg in the group of eggs. The discrimination can be performed, for example, in the same manner as the direct confirmation described above. The discrimination can be performed, for example, by visual inspection. The discrimination can be performed based on feathers in addition to or instead of eyes. When feathers are used for the discrimination, it is preferable to use birds of a lineage that expresses pigments in feathers in the wild type. When the discrimination is performed visually, the discrimination step may, for example, remove a part of the eggshell of each egg, and after the discrimination, the eggshell may be returned to its original position, or may be performed using an egg candling device as described above. The discrimination can be performed, for example, when the eye color of the bird of each egg is the same as the eye color of a male bird that has the wild type eye pigment expression gene on the Z chromosome in a homozygous or heterozygous form, and / or when the eye color of the bird of the egg is the same as the eye color of a female bird that has the wild type eye pigment expression gene on the Z chromosome. The bird of the egg can be evaluated as, for example, male. On the other hand, if the eye color of the bird of each egg is the same as the eye color of a male bird having a homozygous loss-of-function of the eye pigment expression gene on the Z chromosome, and / or the eye color of a female bird having a loss-of-function of the wild-type eye pigment expression gene on the Z chromosome, the bird of the egg can be evaluated as, for example, female. As a specific example, if the eye pigment expression gene is the SLC45A2 gene, and the eye color of the bird of each egg is black, the bird of the egg can be determined to be male, and if the eye color of the bird of each egg is not black, for example, transparent or red, the bird of the egg can be determined to be female.

[0081] The population of eggs subjected to the discrimination step is, for example, a population including eggs that have been incubated for 0 to 10 days, 0 to 7 days, 3 to 7 days, 4 to 7 days, 5 to 7 days, or 6 to 7 days, based on the day of egg-laying (incubation day 0), and preferably a population including eggs that have been incubated for 3 to 7 days, 4 to 7 days, 5 to 7 days, or 6 to 7 days.

[0082] In the discrimination method of the present disclosure, the birds in the eggs whose sex has been discriminated in the discrimination step may or may not be further raised. If the bird in the egg is female, for example, it is preferable to further raise it. If the bird in the egg is male, for example, it is preferable not to raise it. The raising conditions and raising method of the birds can be appropriately determined, for example, according to the growth stage and breed of the birds. In the raising, for example, the birds may be raised to any growth stage.

[0083] In the discrimination method of the present disclosure, sex discrimination is performed on the group of eggs, but the present disclosure is not limited thereto, and for example, the discrimination may be performed on one or more eggs. The description of the group of eggs can be applied to the egg, except that the number of eggs is one or more.

[0084] <Production method> In another aspect, the present disclosure provides a method for producing the bird of the present disclosure using the bird of the present disclosure. The method for producing the bird of the present disclosure includes a step of mating a male bird with a female bird. The male bird is a bird having the functionally lost pigment expression gene homozygously on the Z chromosome, and the female bird is a bird having a wild-type eye pigment expression gene for the eye pigment expression gene on the Z chromosome.

[0085] In the production method of the present disclosure, the birds of the present disclosure are used in the mating step, and therefore, for example, birds in which the eye pigment expression gene has lost its function can be produced.

[0086] In the mating step, the male bird used as the first parent may be a bird that has the functionally-disordered pigment expression gene homozygously on the Z chromosome. The functionally-disordered pigment expression gene may be functionally-disordered in all cells of the bird, or may be functionally-disordered in gametes (sperm). When the functionally-disordered pigment expression gene is functionally-disordered in the sperm, the bird may be called, for example, a chimeric bird.

[0087] The production method of the present disclosure may include a step (selection step) of selecting, prior to the mating, from target male birds, male birds having the functionally lost pigment expression gene on the Z chromosome in a homozygous form. The selection step may be carried out, for example, in accordance with the above-mentioned direct or indirect confirmation, and specifically, the selection may be carried out based on the eye color of the target male bird, or may be carried out using the base sequence of the eye pigment expression gene as an index, or may be carried out using the expression amount of the eye pigment expression gene or the eye pigment expression protein as an index.

[0088] When the base sequence of the eye pigment expression gene is used as an index, in the selection step, the detection of the loss of function of the eye pigment expression gene may be performed, for example, by decoding the base sequence of the eye pigment expression gene of the target male bird and comparing it with the base sequence of the corresponding wild-type eye pigment expression gene or the loss-of-function form of the eye pigment expression gene. The decoding of the base sequence can be performed, for example, using a sequencer. In the selection step, for example, when the base sequence of the pigment expression gene of the target male bird is a base sequence in which a loss-of-function mutation has been introduced into the base sequence of the wild-type eye pigment expression gene of the corresponding bird, or when it matches the base sequence of the loss-of-function form of the eye pigment expression gene of the corresponding bird, the bird is selected as the bird of the present disclosure. The conditions for the selection will be described later. The base sequence of the wild-type eye pigment expression gene can refer to the base sequence of the wild-type eye pigment expression gene of each of the birds described above. In addition, the base sequence of the loss-of-function form of the eye pigment expression gene can refer to the base sequence of the loss-of-function form of the eye pigment expression gene of each of the birds described above. The comparison of the base sequences can be carried out, for example, by using a base sequence analysis software (for example, the above-mentioned BLAST, etc.). In the selection step, the region for comparing the base sequences may be an intron region of an eye pigment expression gene or an exon region of a pigment expression gene, but the latter is preferable. In addition, when the loss of function of the eye pigment expression gene is caused by introducing a mutation such as an insertion, deletion, and / or substitution of one or more bases into the base sequence of the corresponding wild-type eye pigment expression gene, the selection step may be carried out, for example, by using a primer set, a probe, or a combination thereof capable of detecting at least one mutation. The primer set and the probe can be designed, for example, by a general method in this technical field based on the type of the mutation.

[0089] In the selection step, for example, the gene may be determined to be a loss-of-function gene when one or more bases are inserted, deleted, and / or substituted with respect to the wild-type eye pigment expression gene. In addition, in the selection step, for example, the gene may be determined to be a loss-of-function gene when a frameshift mutation is introduced into the wild-type eye pigment expression gene. Furthermore, in the selection step, for example, the gene may be determined to be a loss-of-function gene when the wild-type eye pigment expression gene is partially or completely deleted.

[0090] When the expression level of the eye pigment expression gene is used as an index, the detection of the loss of function of the eye pigment expression gene in the selection step may be carried out, for example, by detecting the function of the mRNA of the eye pigment expression gene or the protein encoded by the eye pigment expression gene of the target male bird. Furthermore, the detection of the loss of function of the eye pigment expression gene in the selection step may be carried out, for example, by detecting the presence or absence of expression of the eye pigment expression gene or the protein encoded by the eye pigment expression gene in the subject bird, or the expression level of the eye pigment expression gene or the protein encoded by the eye pigment expression gene.

[0091] In the selection step, when the judgment is based on the expression of the protein encoded by the eye pigment expression gene, for example, the expression level of at least one of the eye pigment expression gene and the protein encoded by the eye pigment expression gene in the biological sample of the target male bird is measured in the selection step. Then, in the selection step, birds that have lost function of the eye pigment expression gene (birds that have lost function) are selected based on the expression level of at least one of the eye pigment expression gene and the protein encoded by the eye pigment expression gene in the biological sample of the target male bird and a reference value. Specifically, in the selection step, the selection of birds that have lost function among the target male birds can be performed by, for example, comparing the expression level of at least one of the eye pigment expression gene and the protein encoded by the eye pigment expression gene in the biological sample of the target male bird with the reference value.

[0092] The biological sample of the target male bird is not particularly limited and may be, for example, any of the target male bird individual and parts of the target male bird individual, and preferably avian primordial germ cells (PGCs), sperm, etc. The type of biological sample used in the selection step may be, for example, one type, or two or more types.

[0093] In the selection step, the expression level of the eye pigment expression gene can be measured by, for example, semi-quantitative PCR, quantitative PCR, Northern blotting, digital PCR, RNA sequence analysis (RNAseq), etc. In addition, in the selection step, the expression level of the protein encoded by the eye pigment expression gene can be measured by, for example, a method using a spectrophotometer such as an ultraviolet absorption method or a bicinchoninic acid method, or a protein quantification method such as ELISA or Western blotting.

[0094] The reference value may be, for example, the expression level of the eye pigment expression gene or the protein encoded by the eye pigment expression gene in the wild-type bird, or the expression level of the eye pigment expression gene or the protein encoded by the eye pigment expression gene in a bird having a loss-of-function form of the eye pigment expression gene. When the expression level of the eye pigment expression gene in the loss-of-function bird is used as the reference value, the loss-of-function bird may be, for example, a bird in which one of the two eye pigment expression genes located on each of a pair of chromosomes is lost, i.e., a heterozygous bird, or a bird in which both genes are lost, i.e., a homozygous bird, but is preferably a homozygous bird. The expression level of the eye pigment expression gene or the protein encoded by the eye pigment expression gene as the reference value can be obtained, for example, by measuring the expression level of the eye pigment expression gene or the protein encoded by the eye pigment expression gene in a biological sample collected under the same conditions as the biological sample of the male bird of interest, using the same method as the biological sample of the male bird of interest. The reference value may be measured, for example, in advance, or may be measured simultaneously with a biological sample from the subject male bird.

[0095] In this case, the method for evaluating whether or not the eye pigment expression gene in the target male bird has lost its function in the selection step is not particularly limited, and can be appropriately determined depending on the type of the reference value.

[0096] As specific examples, if the expression level of an eye pigment expression gene in a biological sample from the target male bird is the same (no significant difference) as the expression level of the eye pigment expression gene in a bird that has the wild-type eye pigment expression gene in a homozygous form, if the expression level of an eye pigment expression gene in a biological sample from the target male bird is (significantly) higher than the expression level of the eye pigment expression gene in a bird that has the wild-type eye pigment expression gene in a homozygous form, and / or if the expression level of an eye pigment expression gene in a biological sample from the target male bird is (significantly) higher than the expression level of the eye pigment expression gene in a biological sample from a bird that has a loss-of-function form of the eye pigment expression gene in a homozygous or heterozygous form, the target male bird can be evaluated as not having loss-of-function of the eye pigment expression gene, for example. On the other hand, if the expression level of the eye pigment expression gene in a biological sample from the target male bird is (significantly) lower than the expression level of the eye pigment expression gene in a biological sample from a bird having the wild-type eye pigment expression gene in a homozygous form, if the expression level of the eye pigment expression gene in a biological sample from the target male bird is the same (not significantly different) as the expression level of the eye pigment expression gene in a biological sample from a bird having a homozygous loss-of-function form of the eye pigment expression gene, and / or if the expression level of the eye pigment expression gene in a biological sample from the target male bird is (significantly) lower than the expression level of the eye pigment expression gene in a biological sample from a bird having a homozygous or heterozygous loss-of-function form of the eye pigment expression gene, the target male bird can be evaluated as having, for example, a loss-of-function of the eye pigment expression gene.

[0097] Furthermore, if the expression level of the eye pigment expression protein in a biological sample from the target male bird is the same (no significant difference) as the expression level of the eye pigment expression protein in a bird that has the wild-type eye pigment expression protein in a homozygous form, if the expression level of the eye pigment expression protein in a biological sample from the target male bird is (significantly) higher than the expression level of the eye pigment expression protein in a bird that has the wild-type eye pigment expression protein in a homozygous form, and / or if the expression level of the eye pigment expression protein in a biological sample from the target male bird is (significantly) higher than the expression level of the eye pigment expression protein in a biological sample from a bird that has a loss-of-function form of the eye pigment expression protein in a homozygous or heterozygous form, the target male bird can be evaluated as not having loss-of-function of the eye pigment expression gene, for example. On the other hand, if the expression level of the eye pigment-expressing protein in a biological sample from the target male bird is (significantly) lower than the expression level of the eye pigment-expressing protein in a biological sample from a bird having the wild-type eye pigment-expressing protein in a homozygous form, if the expression level of the eye pigment-expressing protein in a biological sample from the target male bird is the same (not significantly different) as the expression level of the eye pigment-expressing protein in a biological sample from a bird having a homozygous loss-of-function form of the eye pigment-expressing protein, and / or if the expression level of the eye pigment-expressing protein in a biological sample from the target male bird is (significantly) lower than the expression level of the eye pigment-expressing protein in a biological sample from a bird having a homozygous or heterozygous loss-of-function form of the eye pigment-expressing protein, the target male bird can be evaluated as having, for example, a loss-of-function of the eye pigment-expressing gene.

[0098] Then, in the selection step, for example, birds that have been evaluated as having a loss of function of the eye pigment expression gene are selected as male birds to be used as the first parents.

[0099] In the selection step, for example, the genotype of the eye pigment expression gene may be evaluated based on the expression level of the eye pigment expression gene. Specifically, the genotype may be evaluated as a homozygous type of a wild-type gene (normal gene), a heterozygous type of a wild-type gene (normal gene) and a loss-of-function gene, or a homozygous type of a loss-of-function gene. In this case, the selection step can be carried out by using birds (wild-type birds) having the wild-type eye pigment expression gene in a homozygous type, and birds (heterozygous birds or homozygous birds) having a loss-of-function form of the eye pigment expression gene in a heterozygous type or homozygous type, respectively, as the reference value. Specifically, in the selection step, when the expression level of the target gene in the target male bird is equivalent to the expression level of the target gene in the wild-type bird, the heterozygous bird, or the homozygous bird, the target male bird can be evaluated to have the same genotype as, for example, a bird having an equivalent expression level. In this way, in the selection step, a male bird having a homozygous type of the loss-of-function form can be selected as the male bird.

[0100] In the production method of the present disclosure, it is preferable to further raise the male birds selected in the selection step for use in the mating step. The raising conditions and raising methods for the birds can be appropriately determined depending on, for example, the growth stage and the breed of the birds. In the raising, for example, the birds may be raised to any growth stage.

[0101] The production method of the present disclosure may further include a collection step of collecting sperm from the male birds obtained by the selection step.

[0102] The production method of the present disclosure may include, prior to the mating, a step of producing a male bird having the functionally disabled pigment expression gene homozygously on the Z chromosome from the target male bird (production step). The production step can also be referred to as, for example, a step of causing the function of the eye pigment gene of the target male bird to be disabled (function loss step).

[0103] The production process may be carried out by introducing a loss-of-function mutation into the eye pigment expression gene, or by introducing a polynucleotide that suppresses expression of the eye pigment expression gene, or by mating a male bird having the function-loss of the pigment expression gene homozygous on the Z chromosome with a female bird having the function-loss of the pigment expression gene on the Z chromosome, i.e., by hybrid introgression of a function-loss form of the eye pigment expression gene.

[0104] When a loss-of-function mutation is introduced into the eye pigment expression gene, the loss-of-function step, for example, introduces a loss-of-function mutation into the eye pigment expression gene of the target bird. The target bird has the eye pigment expression gene on the Z chromosome. For this reason, in the loss-of-function step, for example, the eye pigment expression gene of one of the pair of Z chromosomes in the target male bird may be lost in function, or the eye pigment expression genes of both Z chromosomes may be lost in function, but the latter is preferred. In the former case, that is, when the eye pigment expression gene of one Z chromosome is lost in function, in the loss-of-function step, it is preferable to crossbreed the obtained male birds to obtain male birds having the function-loss body homozygous on the Z chromosome. In addition, in the loss-of-function step, for example, the eye pigment expression gene of one Z chromosome in the target female bird may be lost in function. In this case, in the loss-of-function step, it is preferable to crossbreed the obtained female birds to obtain male birds having the function-loss body homozygous on the Z chromosome.

[0105] The loss of function of the eye pigment expression gene can be achieved, for example, by introducing a mutation as described above. The above explanation can be applied to the mutation, and it is preferably a nonsense mutation or a frameshift mutation. The loss of function mutation can be introduced, for example, by deleting, substituting, inserting, and / or adding one or several bases to each gene (base sequence of each gene), and is preferably introduced by partially or completely deleting the wild-type eye pigment expression gene.

[0106] In the loss-of-function step, the region into which a loss-of-function mutation is introduced into the eye pigment expression gene may be an intron region or an exon region of the eye pigment expression gene, but is preferably the latter.

[0107] The loss of function of the eye pigment expression gene can be caused, for example, by introducing a mutation into the eye pigment expression gene of the target bird by a conventional method. The method of introducing the mutation can be carried out, for example, by homologous recombination; genome editing technology using the above-mentioned CRISPR enzymes such as ZFN, TALEN, CRISPR-CAS9, CRISPR-CPF1, etc. The method of introducing a mutation using the genome editing technology can be referred to, for example, Example 1 described later. Specifically, a gene mutation can be introduced into the primordial germ cell (PGC) or ES cell of the bird using the genome editing technology. The method of introducing the mutation may also be carried out, for example, by a random mutagenesis method. Examples of the random mutagenesis method include radiation irradiation treatment using α rays, β rays, γ rays, X-rays, etc.; chemical treatment using a mutagen such as ethyl methanesulfonate (EMS) or ethynylnitrosourea (ENU); heavy ion beam treatment; and the like. The above-mentioned methods of introducing the mutation may also be carried out, for example, using a commercially available kit or the like.

[0108] When introducing a polynucleotide that suppresses the expression of the eye pigment expression gene, the method of introducing the polynucleotide is not particularly limited, and can be carried out by, for example, RNA interference, antisense RNA, genome editing technology, etc. An expression cassette such as an expression vector containing the polynucleotide can be introduced into the target bird by, for example, microinjection, polyethylene glycol method, electroporation method, particle gun method, etc. The target bird may be, for example, any of primordial germ cells, ES cells, eggs, embryos, chicks, young birds, young birds, and adult birds, but preferably, primordial germ cells or ES cells.

[0109] In the production method of the present disclosure, it is preferable to select cells in which a loss-of-function mutation has been introduced into the eye pigment expression gene after the introduction of the mutation. The selection can be carried out, for example, in the same manner as in the selection step described above, and the description thereof can be used.

[0110] After the introduction of the mutation, the cells into which the mutation has been introduced may be transplanted, for example, into the target male bird by a conventional method. The transplantation may be into the blastoderm of an early embryo, into the blood, into the gonad region, etc. The cells into which the mutation has been introduced may be cultured before the transplantation.

[0111] After the transplantation, it is preferable to further raise the target male bird for use in the mating step. The conditions and methods for raising the bird can be appropriately determined depending on, for example, the growth stage and the breed of the bird. In the raising, the bird may be raised to any growth stage.

[0112] The production method of the present disclosure may further include a collection step of collecting sperm from the male bird obtained by the production step. EXAMPLES

[0113] The present disclosure will be described in detail below using examples, but the present disclosure is not limited to the aspects described in the examples.

[0114] [Example 1] The researchers created male chickens that were homozygous for loss of function of the SLC45A2 gene in their primordial germ cells, mated them with wild-type female chickens, and confirmed that the sex of the birds in the eggs obtained by this mating could be determined based on the eye color of the birds in the eggs.

[0115] The gRNA (SEQ ID NO: 4) of chicken SLC45A2 gene was cloned into MAD7 (ST7) expression vector optimized for gene editing of primordial germ cells (PGCs). After the cloning, chicken PGCs were obtained from E3 (embryonic day 3) embryos of BPR (Barred Plymouth Rock) chickens under the culture conditions described in Reference 2. After the acquisition, electroporation was performed using the Neon Transfection System (Thermo Fisher Scientific) to introduce the cloned gRNA into the PGCs. Reference 2: Chen, YC, Lin, SP, Chang, YY, Chang, WP, Wei, LY, Liu, HC, Huang, JF, Pain, B., and Wu, SC (2019). In vitro culture and characterization of duck primordial germ cells. Poult Sci 98, 1820-1832. 10.3382 / ps / pey515.

[0116] gRNA for chicken SLC45A2 gene (SEQ ID NO: 4) 5'- TTTGACGTCTGCTCTCATGAAGATA 3'

[0117] Two days after the electroporation, fluorescent cell enrichment sorting was performed using a BD FACSMelody cell sorter (BD Biosciences). Furthermore, in order to isolate SLC45A2-KO clones, the PGC population obtained by the sorting was cultured for one week. After the culture, the cells were distributed to one well of a 96-well plate using a cell sorter. The genotype of the obtained clones in the target region of the SLC45A2 gene was then determined using Sanger sequencing. The results are shown in FIG. 1.

[0118] Figure 1 shows the genotype of the target region of the SLC45A2 gene of the obtained clone. As shown in Figure 1, in the second exon of the SLC45A2 gene, the 182nd amino acid, lysine (K), was replaced with arginine (R), and the 183rd amino acid, alanine (A), to the 205th amino acid, threonine (T), were deleted. These results suggest that gene editing has produced a clone of the SLC45A2 gene with loss of function due to frameshift mutation and / or splice mutation.

[0119] After the genotype was determined, a total of 5 × 10 4 PGCs from the SLC45A2-KO clones were transplanted into the circulatory system of E3 recipient chickens to generate chimeric chickens (F0). Then, offspring of SLC45A2-KO chickens (F1) were produced. Specifically, semen collected from sexually mature male chimeric chickens was artificially inseminated into wild-type breeding female chickens. After the artificial insemination, a population of F1 chicken eggs was obtained. The chickens in the eggs were examined for eye pigmentation. These results are shown in Figures 2 and 3.

[0120] FIG. 2 is a photograph showing the eye color of chickens on the 7th day of incubation. In FIG. 2(A), the upper row shows a male chicken whose whole body was observed, and the lower row shows a male chicken whose eyes were observed. In FIG. 2(B), the upper row shows a female chicken whose whole body was observed, and the lower row shows a female chicken whose eyes were observed. FIG. 3 is a photograph showing the eye color of chickens on the 10th day of incubation. In FIG. 3(A), the upper row shows a male chicken whose both eyes were observed from the head, and the lower row shows a male chicken whose right eye was observed from the side of the face. In FIG. 3(B), the upper row shows a female chicken whose both eyes were observed from the head, and the lower row shows a female chicken whose right eye was observed from the side of the face. As shown in FIG. 2 and FIG. 3, on the 7th day and the 10th day of hatching, when the chicken was male, the eyes were black, whereas when the chicken was female, the eyes were not black. From these results, it was found that in chickens obtained by the method of the present disclosure, males expressed eye pigments, while females suppressed the expression of eye pigments. It was also found that when the chickens obtained by the method of the present disclosure were female, the eye pigments were suppressed and the eye color changed (became transparent) when a loss-of-function mutation was introduced into the SLC45A2 gene. Therefore, it can be said that the discrimination method of the present disclosure can be evaluated by an optical method using an egg inspection device or the like. Furthermore, it was found that the discrimination method of the present disclosure can discriminate between male and female chickens on the 7th day after hatching.

[0121] Although the present disclosure has been described above with reference to the embodiments and examples, the present disclosure is not limited to the above-mentioned embodiments and examples. Various modifications that can be understood by a person skilled in the art can be made to the configuration and details of the present disclosure within the scope of the present disclosure.

[0122] All patents, patent applications, and publications cited herein are hereby incorporated by reference in their entirety as if the contents were specifically set forth herein.

[0123] <Additional Notes> Some or all of the above-described embodiments and examples may be described as follows, but are not limited to the following: <Method for determining sex> (Appendix 1) determining, for a population of avian eggs, the sex of the avian based on the eye color of each egg in the population of eggs; When the bird in the egg is a male bird, the male bird contains a heterozygous eye pigment expression gene and a wild-type eye pigment expression gene on the Z chromosome, A method for determining the sex of a bird, wherein when the bird in the egg is a female bird, the female bird contains an eye pigment expression gene on the Z chromosome that has been disrupted in function. (Appendix 2) Prior to the discrimination, a step of mating male parent birds with female parent birds to prepare a population of eggs, The male parent bird has a loss of function for the eye pigment expression gene and contains the loss-of-function pigment expression gene homozygously; The method of distinguishing between males and females described in Appendix 1, wherein the female parent bird contains a wild-type eye pigment expression gene for the eye pigment expression gene. (Appendix 3) The method for distinguishing between eye pigment expression genes described in Appendix 1 and Appendix 2, wherein the loss-of-function pigment expression gene is a mutant gene in which one or more bases are deleted, substituted, inserted and / or added to the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed. (Appendix 4) The method of distinguishing between eye pigment expression genes described in Appendix 3, wherein the loss-of-function pigment expression gene is a mutant gene in which at least some bases are deleted from the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed. (Appendix 5) A method for distinguishing between eye pigment expression genes described in any one of Appendix 1 to 4, wherein the loss-of-function pigment expression gene is a mutant gene that contains a frameshift mutation relative to the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed. (Appendix 6) A method for distinguishing between eye pigment expression genes described in any one of Appendix 1 to 5, wherein the loss-of-function pigment expression gene is a mutant gene that includes a splice mutation relative to the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed. (Appendix 7) A method for distinguishing between eye pigment-expressing and non-eye pigment-expressing diseases, comprising the step of: (Appendix 8) the eye pigment expression gene is the SLC45A2 gene; A method for distinguishing between an SLC45A2 gene and a wild-type SLC45A2 gene, comprising: a step of: determining whether or not an SLC45A2 gene is functional; and determining whether or not an SLC45A2 gene is functional. (Appendix 9) A method for determining whether or not a function of the SLC45A2 gene is a wild-type SLC45A2 gene, wherein the lost function SLC45A2 gene lacks the base sequence of SEQ ID NO: 3 in the second exon of the wild-type SLC45A2 gene. (Appendix 10) The method for determining whether or not the SLC45A2 gene is a gene comprising the following polynucleotide (S): (S) any one of the following polynucleotides (S1) to (S7): (S1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1; (S2) a polynucleotide encoding a protein having the function of expressing eye pigment, the polynucleotide consisting of a base sequence in which several bases have been deleted, substituted, inserted, and / or added in the base sequence of (S1); (S3) a polynucleotide having a base sequence having 90% or more identity to the base sequence of (S1), and encoding a protein having the function of expressing eye pigment; (S4) a polynucleotide having a nucleotide sequence complementary to a polynucleotide that hybridizes under stringent conditions to the polynucleotide having the nucleotide sequence of (S1), and encoding a protein having the function of expressing eye pigment; (S5) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2; (S6) a polynucleotide encoding a protein having an eye pigment expression function, comprising an amino acid sequence in which several amino acids are deleted, substituted, inserted, and / or added in the amino acid sequence of SEQ ID NO:2; (S7) A polynucleotide that consists of an amino acid sequence having 90% or more identity to the amino acid sequence of SEQ ID NO:2 and encodes a protein having the function of expressing eye pigment. (Appendix 11) the pigment expression gene whose function has been lost is a SLC45A2 gene whose function has been lost, The method for determining whether or not the SLC45A2 gene has lost its function is a gene comprising the following polynucleotide (M): (M1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1; (M2) a polynucleotide encoding a protein having a suppressed expression function of eye pigment, the polynucleotide consisting of a base sequence in which several bases are deleted, substituted, inserted, and / or added in the base sequence of (M1); (M3) a polynucleotide having a base sequence having 80% or more identity to the base sequence of (M1), encoding a protein having a suppressed eye pigment expression function; (M4) a polynucleotide having a nucleotide sequence complementary to a polynucleotide that hybridizes under stringent conditions to a polynucleotide having the nucleotide sequence of (M1), and encoding a protein in which the expression function of eye pigment is suppressed; (M5) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2; (M6) a polynucleotide encoding a protein having an amino acid sequence in which several amino acids are deleted, substituted, inserted, and / or added in the amino acid sequence of SEQ ID NO:2 and in which the expression function of eye pigment is suppressed; (M7) A polynucleotide encoding a protein having an amino acid sequence having 80% or more identity to the amino acid sequence of SEQ ID NO:2, the protein having a suppressed eye pigment expression function. (Appendix 12) the pigment expression gene whose function has been lost is a SLC45A2 gene whose function has been lost, The method according to any one of Appendix 7 to 11, wherein the SLC45A2 gene having lost its function is a gene comprising the following polynucleotide (T): (T) any one of the following polynucleotides (T1) to (T4): (T1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1 in which the 545th to 615th nucleotides are deleted; (T2) a polynucleotide encoding a protein with suppressed expression function of eye pigment, the polynucleotide comprising a base sequence in which several bases have been deleted, substituted, inserted, and / or added in the base sequence of the polynucleotide of (T1); (T3) a polynucleotide having a base sequence having 80% or more identity to the base sequence of the polynucleotide of (T1), encoding a protein having a suppressed function of expressing eye pigment; (T4) A polynucleotide having a base sequence complementary to a polynucleotide that hybridizes under stringent conditions to a polynucleotide having the base sequence of (T1), and encoding a protein whose eye pigment expression function is suppressed. (Appendix 13) 13. The method of any one of claims 1 to 12, wherein the bird is selected from the group consisting of chickens, quails, turkeys, ducks, geese, ostriches, pigeons, guinea fowl, pheasants, wild ducks, and emus. <Birds> (Appendix 14) Birds have a loss of function for eye pigmentation genes on the Z chromosome. (Appendix 15) The bird described in Appendix 14, wherein the functional pigment expression gene is a mutant gene in which one or more bases are deleted, substituted, inserted and / or added in the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed. (Appendix 16) The bird described in Appendix 15, wherein the pigment expression gene that has lost its function is a mutant gene in which at least some bases are deleted from the base sequence of a wild-type pigment expression gene, and the expression function of eye pigments is suppressed. (Appendix 17) The bird described in any of Appendices 14 to 16, wherein the pigment expression gene that has lost its function is a mutant gene that contains a frameshift mutation relative to the base sequence of a wild-type pigment expression gene, and the expression function of eye pigments is suppressed. (Appendix 18) A bird described in any of Appendices 14 to 17, wherein the functional pigment expression gene is a mutant gene that includes a splice mutation relative to the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed. (Appendix 19) 19. The bird described in any of Appendices 14 to 18, wherein the pigment expression gene is the SLC45A2 gene. (Appendix 20) the eye pigment expression gene is the SLC45A2 gene; A bird according to any one of Appendices 14 to 17, wherein the loss-of-function SLC45A2 gene is a mutant gene containing a mutation in the second exon of the wild-type SLC45A2 gene, and the expression function of eye pigment is suppressed. (Appendix 21) A bird according to Appendix 20, wherein the functionally impaired SLC45A2 gene lacks the nucleotide sequence of SEQ ID NO: 3 in the second exon of the wild-type SLC45A2 gene. (Appendix 22) 22. The bird according to any one of Appendices 19 to 21, wherein the SLC45A2 gene is a gene comprising the polynucleotide (S) below: (S) any one of the following polynucleotides (S1) to (S7): (S1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1; (S2) a polynucleotide encoding a protein having the function of expressing eye pigment, the polynucleotide consisting of a base sequence in which several bases have been deleted, substituted, inserted, and / or added in the base sequence of (S1); (S3) a polynucleotide having a base sequence having 80% or more identity to the base sequence of (S1), and encoding a protein having a function of expressing eye pigment; (S4) a polynucleotide having a nucleotide sequence complementary to a polynucleotide that hybridizes under stringent conditions to the polynucleotide having the nucleotide sequence of (S1), and encoding a protein having the function of expressing eye pigment; (S5) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2; (S6) a polynucleotide encoding a protein having an eye pigment expression function, comprising an amino acid sequence in which several amino acids are deleted, substituted, inserted, and / or added in the amino acid sequence of SEQ ID NO:2; (S7) A polynucleotide that consists of an amino acid sequence having 80% or more identity to the amino acid sequence of SEQ ID NO:2 and encodes a protein having the function of expressing eye pigment. (Appendix 23) the pigment expression gene whose function has been lost is a SLC45A2 gene whose function has been lost, The bird according to any one of Appendices 19 to 22, wherein the function-disrupted SLC45A2 gene is a gene comprising a polynucleotide (M) below: (M1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1; (M2) a polynucleotide encoding a protein having a suppressed expression function of eye pigment, the polynucleotide consisting of a base sequence in which several bases are deleted, substituted, inserted, and / or added in the base sequence of (M1); (M3) a polynucleotide having a base sequence having 80% or more identity to the base sequence of (M1), encoding a protein having a suppressed eye pigment expression function; (M4) a polynucleotide having a nucleotide sequence complementary to a polynucleotide that hybridizes under stringent conditions to a polynucleotide having the nucleotide sequence of (M1), and encoding a protein in which the expression function of eye pigment is suppressed; (M5) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2; (M6) a polynucleotide encoding a protein having an amino acid sequence in which several amino acids are deleted, substituted, inserted, and / or added in the amino acid sequence of SEQ ID NO:2 and in which the expression function of eye pigment is suppressed; (M7) A polynucleotide encoding a protein having an amino acid sequence having 80% or more identity to the amino acid sequence of SEQ ID NO:2, the protein having a suppressed eye pigment expression function. (Appendix 24) the pigment expression gene whose function has been lost is a SLC45A2 gene whose function has been lost, The bird according to any one of Appendix 19 to 23, wherein the function-disrupted SLC45A2 gene is a gene comprising a polynucleotide (T) below: (T) any one of the following polynucleotides (T1) to (T4): (T1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1 in which the 546th to 615th nucleotides are deleted; (T2) a polynucleotide encoding a protein with suppressed expression function of eye pigment, the polynucleotide comprising a base sequence in which several bases have been deleted, substituted, inserted, and / or added in the base sequence of the polynucleotide of (T1); (T3) a polynucleotide having a base sequence having 80% or more identity to the base sequence of the polynucleotide of (T1), encoding a protein having a suppressed function of expressing eye pigment; (T4) A polynucleotide having a base sequence complementary to a polynucleotide that hybridizes under stringent conditions to a polynucleotide having the base sequence of (T1), and encoding a protein whose eye pigment expression function is suppressed. (Appendix 25) 25. The bird according to any one of claims 14 to 24, wherein the bird is selected from the group consisting of chickens, quails, turkeys, ducks, geese, ostriches, pigeons, guinea fowl, pheasants, wild ducks, and emus. (Appendix 26) the bird is male, 26. A bird described in any one of appendix 14 to 25, having the functionally disabled pigment expression gene homozygously. <Bird part> (Appendix 27) 7. A part of an avian species according to any one of appendixes 14 to 26. (Appendix 28) 28. The portion of claim 27, wherein the portion is an edible portion. <Production method> (Appendix 29) The method includes a step of mating a male bird with a female bird, The male bird is a bird as described in appended claim 26; A method for producing a bird, wherein the female bird is a bird that contains a wild-type eye pigment expression gene on the Z chromosome. (Appendix 30) The production method described in Appendix 29, comprising a step of selecting birds in which the eye pigment expression gene has lost its function from the birds or progeny lines obtained by the breeding. (Appendix 31) The method of producing the bird of claim 29 or 30, comprising the step of selecting the bird of claim 26 from target male birds prior to said mating. (Appendix 32) The method of producing the bird of claim 29 or 30, comprising the step of producing the bird of claim 26 from a target male bird prior to said mating. (Appendix 33) The production method described in Appendix 31 or 32, wherein the pigment expression gene whose function has been lost is a mutant gene in which one or more bases have been deleted, substituted, inserted and / or added to the base sequence of a wild-type eye pigment expression gene, and the expression function of eye pigment is suppressed. (Appendix 34) The production method described in Appendix 33, wherein the pigment expression gene whose function has been lost is a mutant gene in which at least some bases are deleted from the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed. (Appendix 35) The method for producing an eye pigment according to any one of claims 31 to 34, wherein the pigment expression gene whose function has been lost is a mutant gene containing a frameshift mutation relative to the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed. (Appendix 36) A production method described in any of Appendices 31 to 35, wherein the pigment expression gene whose function has been lost is a mutant gene that contains a splice mutation relative to the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed. (Appendix 37) 37. The method of any one of claims 31 to 36, wherein the eye pigment expression gene is the SLC45A2 gene. (Appendix 38) the eye pigment expression gene is the SLC45A2 gene; A method for producing an SLC45A2 gene having lost its function, comprising: a mutant gene containing a mutation in the second exon of the wild-type SLC45A2 gene; and suppressing the expression function of eye pigments, comprising the method for producing an SLC45A2 gene having lost its function; (Appendix 39) The method for producing the SLC45A2 gene having lost its function, wherein the base sequence of SEQ ID NO:3 in the second exon of the wild-type SLC45A2 gene is deleted. (Appendix 40) 40. The method for producing the SLC45A2 gene according to any one of claims 37 to 39, wherein the SLC45A2 gene comprises the polynucleotide (S) below: (S) any one of the following polynucleotides (S1) to (S7): (S1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1; (S2) a polynucleotide encoding a protein that expresses eye pigment, the polynucleotide consisting of a base sequence in which several bases have been deleted, substituted, inserted, and / or added in the base sequence of (S1); (S3) a polynucleotide having a base sequence having 80% or more identity to the base sequence of (S1), and encoding a protein that expresses eye pigment; (S4) a polynucleotide that has a nucleotide sequence complementary to a polynucleotide that hybridizes under stringent conditions to the polynucleotide having the nucleotide sequence of (S1), and that encodes a protein that expresses eye pigment; (S5) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2; (S6) a polynucleotide comprising an amino acid sequence in which several amino acids are deleted, substituted, inserted, and / or added in the amino acid sequence of SEQ ID NO:2, and encoding a protein that expresses eye pigment; (S7) A polynucleotide having an amino acid sequence having 80% or more identity to the amino acid sequence of SEQ ID NO:2, and encoding a protein that expresses eye pigment. (Appendix 41) the pigment expression gene whose function has been lost is a SLC45A2 gene whose function has been lost, The method for producing the SLC45A2 gene having lost its function, comprising the following polynucleotide (M): (M1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1; (M2) a polynucleotide encoding a protein having a suppressed expression function of eye pigment, the polynucleotide consisting of a base sequence in which several bases are deleted, substituted, inserted, and / or added in the base sequence of (M1); (M3) a polynucleotide having a base sequence having 80% or more identity to the base sequence of (M1), encoding a protein having a suppressed eye pigment expression function; (M4) a polynucleotide having a nucleotide sequence complementary to a polynucleotide that hybridizes under stringent conditions to a polynucleotide having the nucleotide sequence of (M1), and encoding a protein in which the expression function of eye pigment is suppressed; (M5) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2; (M6) a polynucleotide encoding a protein having an amino acid sequence in which several amino acids are deleted, substituted, inserted, and / or added in the amino acid sequence of SEQ ID NO:2 and in which the expression function of eye pigment is suppressed; (M7) A polynucleotide encoding a protein having an amino acid sequence having 80% or more identity to the amino acid sequence of SEQ ID NO:2, the protein having a suppressed eye pigment expression function. (Appendix 42) the pigment expression gene whose function has been lost is a SLC45A2 gene whose function has been lost, The method according to any one of Appendices 37 to 41, wherein the function-disrupted SLC45A2 gene is a gene comprising a polynucleotide (T) below: (T) any one of the following polynucleotides (T1) to (T4): (T1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1 in which the 545th to 615th nucleotides are deleted; (T2) a polynucleotide encoding a protein with suppressed expression function of eye pigment, the polynucleotide comprising a base sequence in which several bases have been deleted, substituted, inserted, and / or added in the base sequence of the polynucleotide of (T1); (T3) a polynucleotide having a base sequence having 80% or more identity to the base sequence of the polynucleotide of (T1), encoding a protein having a suppressed function of expressing eye pigment; (T4) A polynucleotide having a base sequence complementary to a polynucleotide that hybridizes under stringent conditions to a polynucleotide having the base sequence of (T1), and encoding a protein whose eye pigment expression function is suppressed. (Appendix 43) 43. The method of any one of claims 29 to 42, wherein the bird is selected from the group consisting of chicken, quail, turkey, duck, goose, ostrich, pigeon, guinea fowl, pheasant, duck, and emu. (Appendix 44) A population of bird eggs, When the bird in the egg is a male bird, the male bird contains a heterozygous eye pigment expression gene and a wild-type eye pigment expression gene on the Z chromosome, A population of avian eggs, wherein, when the bird in the egg is a female bird, the female bird comprises a loss-of-function eye pigment gene on the Z chromosome. (Appendix 45) A population of avian eggs as described in Appendix 44 for use in a method for determining the sex of birds as described in any one of Appendixes 1 to 13. [Industrial Applicability]

[0124] As described above, the bird of the present disclosure has a loss of function of the eye pigment expression gene on the Z chromosome, making it possible to determine the sex of the bird. Therefore, the present invention is extremely useful in, for example, the fields of bird breeding and livestock farming.

Claims

1. determining, for a population of avian eggs, the sex of the avian based on the eye color of each egg in the population of eggs; When the bird in the egg is a male bird, the male bird contains a heterozygous eye pigment expression gene and a wild-type eye pigment expression gene on a Z chromosome, A method for determining the sex of a bird, wherein when the bird in the egg is a female bird, the female bird contains an eye pigment expression gene on a Z chromosome that has been knocked out of function.

2. Prior to the discrimination, a step of mating male parent birds with female parent birds to prepare a population of eggs, The male parent bird has a loss of function for the eye pigment expression gene and contains the loss-of-function pigment expression gene homozygously; The method according to claim 1 , wherein the female parent bird contains a wild-type eye pigment expression gene for the eye pigment expression gene.

3. The method of claim 1 or 2, wherein the pigment expression gene that has lost its function is a mutant gene in which one or more bases are deleted, substituted, inserted, and / or added to the base sequence of a wild-type eye pigment expression gene, and the expression function of eye pigment is suppressed.

4. The discrimination method described in claim 3, wherein the pigment expression gene that has lost its function is a mutant gene in which at least some bases are deleted from the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed.

5. The method of claim 1 or 2, wherein the pigment expression gene that has lost its function is a mutant gene that contains a frameshift mutation relative to the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed.

6. The method of claim 1 or 2, wherein the pigment expression gene that has lost its function is a mutant gene that includes a splice mutation relative to the base sequence of a wild-type eye pigment expression gene, and the expression function of eye pigment is suppressed.

7. The method according to claim 1 or 2, wherein the eye pigment expression gene is the SLC45A2 gene.

8. The eye pigment expression gene is the SLC45A2 gene; 3. The method according to claim 1, wherein the SLC45A2 gene having lost its function is a mutant gene comprising a mutation in the second exon of a wild-type SLC45A2 gene, and the expression function of eye pigment is suppressed.

9. The method according to claim 8 , wherein the function-deprived SLC45A2 gene lacks the base sequence of SEQ ID NO: 3 in the second exon of the wild-type SLC45A2 gene.

10. The method according to claim 7, wherein the SLC45A2 gene is a gene comprising the following polynucleotide (S): (S) Any of the following polynucleotides (S1) to (S7): (S1) a polynucleotide consisting of the base sequence of SEQ ID NO: 1; (S2) a polynucleotide encoding a protein having the function of expressing eye pigment, which consists of a base sequence in which 1 to 163 bases are deleted, substituted, inserted, and / or added in the base sequence of (S1); (S3) a polynucleotide having a base sequence having 90% or more identity to the base sequence of (S1), and encoding a protein having the function of expressing eye pigment; (S4) a polynucleotide that has a base sequence complementary to a polynucleotide that hybridizes under stringent conditions to the polynucleotide having the base sequence of (S1), and that encodes a protein having the function of expressing eye pigment; (S5) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO:2; (S6) a polynucleotide encoding a protein having an eye pigment expression function, comprising an amino acid sequence in which 1 to 54 amino acids are deleted, substituted, inserted, and / or added in the amino acid sequence of SEQ ID NO: 2; (S7) A polynucleotide that consists of an amino acid sequence having 90% or more identity to the amino acid sequence of SEQ ID NO: 2 and encodes a protein having the function of expressing eye pigment.

11. the pigment expression gene whose function has been lost is a SLC45A2 gene whose function has been lost, The method of claim 7, wherein the SLC45A2 gene having lost its function is a gene comprising the following polynucleotide (M): (M1) a polynucleotide consisting of the base sequence of SEQ ID NO: 1; (M2) a polynucleotide encoding a protein with suppressed expression function of eye pigment, the polynucleotide consisting of a base sequence in which 1 to 163 bases are deleted, substituted, inserted, and / or added in the base sequence of (M1); (M3) a polynucleotide having a base sequence having 90% or more identity to the base sequence of (M1), encoding a protein having a suppressed expression function of eye pigment; (M4) a polynucleotide having a base sequence complementary to a polynucleotide that hybridizes under stringent conditions to a polynucleotide having the base sequence of (M1), and encoding a protein in which the expression function of eye pigment is suppressed; (M5) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO:2; (M6) a polynucleotide encoding a protein having an amino acid sequence in which 1 to 54 amino acids are deleted, substituted, inserted, and / or added in the amino acid sequence of SEQ ID NO:2, and in which the expression function of eye pigment is suppressed; (M7) A polynucleotide encoding a protein having an amino acid sequence having 90% or more identity to the amino acid sequence of SEQ ID NO:2, the protein having a suppressed eye pigment expression function.

12. the pigment expression gene whose function has been lost is a SLC45A2 gene whose function has been lost, The method according to claim 7, wherein the SLC45A2 gene having lost its function is a gene comprising the following polynucleotide (T): (T) any one of the following polynucleotides (T1) to (T4): (T1) a polynucleotide consisting of the base sequence of SEQ ID NO: 1 in which the 545th to 615th bases are deleted; (T2) a polynucleotide encoding a protein with suppressed expression function of eye pigment, the polynucleotide comprising a base sequence in which 1 to 156 bases are deleted, substituted, inserted, and / or added in the base sequence of the polynucleotide of (T1); (T3) a polynucleotide having a base sequence having 90% or more identity to the base sequence of the polynucleotide of (T1), encoding a protein having a suppressed expression function of eye pigment; (T4) A polynucleotide having a base sequence complementary to a polynucleotide that hybridizes under stringent conditions to a polynucleotide having the base sequence of (T1), and encoding a protein whose eye pigment expression function is suppressed.

13. 3. The method according to claim 1, wherein the bird is selected from the group consisting of chickens, quails, turkeys, ducks, geese, ostriches, pigeons, guinea fowl, pheasants, wild ducks, and emus.

14. Birds that have a loss of function of the eye pigment expression gene on the Z chromosome.

15. The bird described in claim 14, wherein the pigment expression gene that has lost its function is a mutant gene in which one or more bases are deleted, substituted, inserted and / or added in the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed.

16. The bird described in claim 15, wherein the pigment expression gene that has lost its function is a mutant gene in which at least some bases are deleted from the base sequence of a wild-type pigment expression gene, and the expression function of eye pigments is suppressed.

17. The bird described in any one of claims 14 to 16, wherein the pigment expression gene that has lost its function is a mutant gene that contains a frameshift mutation relative to the base sequence of a wild-type pigment expression gene, and the expression function of eye pigments is suppressed.

18. The bird described in any one of claims 14 to 16, wherein the loss-of-function pigment expression gene is a mutant gene that includes a splice mutation relative to the base sequence of a wild-type eye pigment expression gene, and the eye pigment expression function is suppressed.

19. The bird described in any one of claims 14 to 16, wherein the pigment expression gene is the SLC45A2 gene.

20. The eye pigment expression gene is the SLC45A2 gene; The bird according to any one of claims 14 to 16, wherein the loss-of-function SLC45A2 gene is a mutant gene containing a mutation in the second exon of the wild-type SLC45A2 gene, and the expression function of eye pigment is suppressed.

21. The bird according to claim 20, wherein the functionally impaired SLC45A2 gene lacks the base sequence of SEQ ID NO:3 in the second exon of the wild-type SLC45A2 gene.

22. The bird according to claim 19, wherein the SLC45A2 gene is a gene comprising a polynucleotide of the following (S): (S) Any of the following polynucleotides (S1) to (S7): (S1) a polynucleotide consisting of the base sequence of SEQ ID NO: 1; (S2) a polynucleotide encoding a protein having the function of expressing eye pigment, which consists of a base sequence in which 1 to 163 bases are deleted, substituted, inserted, and / or added in the base sequence of (S1); (S3) a polynucleotide having a base sequence having 90% or more identity to the base sequence of (S1), and encoding a protein having the function of expressing eye pigment; (S4) a polynucleotide that has a base sequence complementary to a polynucleotide that hybridizes under stringent conditions to the polynucleotide having the base sequence of (S1), and that encodes a protein having the function of expressing eye pigment; (S5) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO:2; (S6) a polynucleotide encoding a protein having an eye pigment expression function, comprising an amino acid sequence in which 1 to 54 amino acids are deleted, substituted, inserted, and / or added in the amino acid sequence of SEQ ID NO: 2; (S7) A polynucleotide that consists of an amino acid sequence having 90% or more identity to the amino acid sequence of SEQ ID NO: 2 and encodes a protein having the function of expressing eye pigment.

23. the pigment expression gene whose function has been lost is a SLC45A2 gene whose function has been lost, The bird according to claim 19, wherein the SLC45A2 gene that has lost its function is a gene comprising the following polynucleotide (M): (M1) a polynucleotide consisting of the base sequence of SEQ ID NO: 1; (M2) a polynucleotide encoding a protein with suppressed expression function of eye pigment, the polynucleotide consisting of a base sequence in which 1 to 163 bases are deleted, substituted, inserted, and / or added in the base sequence of (M1); (M3) a polynucleotide having a base sequence having 90% or more identity to the base sequence of (M1), encoding a protein having a suppressed expression function of eye pigment; (M4) a polynucleotide having a base sequence complementary to a polynucleotide that hybridizes under stringent conditions to a polynucleotide having the base sequence of (M1), and encoding a protein in which the expression function of eye pigment is suppressed; (M5) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO:2; (M6) a polynucleotide encoding a protein having an amino acid sequence in which 1 to 54 amino acids are deleted, substituted, inserted, and / or added in the amino acid sequence of SEQ ID NO:2, and in which the expression function of eye pigment is suppressed; (M7) A polynucleotide encoding a protein having an amino acid sequence having 90% or more identity to the amino acid sequence of SEQ ID NO:2, the protein having a suppressed eye pigment expression function.

24. the pigment expression gene whose function has been lost is a SLC45A2 gene whose function has been lost, The bird according to claim 19, wherein the SLC45A2 gene that has lost its function is a gene comprising the following polynucleotide (T): (T) any one of the following polynucleotides (T1) to (T4): (T1) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1 in which the 546th to 615th nucleotides are deleted; (T2) a polynucleotide encoding a protein with suppressed expression function of eye pigment, the polynucleotide comprising a base sequence in which 1 to 156 bases are deleted, substituted, inserted, and / or added in the base sequence of the polynucleotide of (T1); (T3) a polynucleotide having a base sequence having 90% or more identity to the base sequence of the polynucleotide of (T1), encoding a protein having a suppressed expression function of eye pigment; (T4) A polynucleotide having a base sequence complementary to a polynucleotide that hybridizes under stringent conditions to a polynucleotide having the base sequence of (T1), and encoding a protein whose eye pigment expression function is suppressed.

25. 17. The bird of any one of claims 14 to 16, wherein the bird is selected from the group consisting of chickens, quails, turkeys, ducks, geese, ostriches, pigeons, guinea fowl, pheasants, wild ducks, and emus.

26. the bird is male, The bird according to any one of claims 14 to 16, which has the functionally disabled pigment expression gene in a homozygous state.

27. The method includes a step of mating a male bird with a female bird, The male bird is the bird of claim 26, A method for producing birds, wherein the female bird is a bird that contains a wild-type eye pigment expression gene on the Z chromosome.

28. The production method according to claim 27, further comprising a step of selecting birds having a loss of function of the eye pigment expression gene from the birds or progeny lines obtained by the breeding.

29. The production method according to claim 27, further comprising a step of selecting, prior to said mating, birds having the functionally disabled pigment expression gene in a homozygous state from among target male birds.

30. The production method according to claim 27, further comprising a step of producing a bird having the functionally disabled pigment expression gene homozygously from the target male bird prior to the mating.

31. A population of bird eggs, When the bird in the egg is a male bird, the male bird contains a heterozygous eye pigment expression gene and a wild-type eye pigment expression gene on a Z chromosome, A population of avian eggs, wherein, when the bird in the egg is a female bird, the female bird comprises a loss-of-function eye pigment gene on the Z chromosome.

32. 32. A population of avian eggs as claimed in claim 31 for use in the method for sexing avian eggs as claimed in claim 1 or 2.

Citation Information

Patent Citations

  • Chicken feathering genotype distinguishing method, primer set therefor, and feathering distinguishing kit

    JP2018023307A

  • Trait selection in birds

    JP2020521494A

  • Molecular sexing of avian subjects

    US20120288856A1

  • Poultry and offspring sex selection

    WO2018013759A1

  • Birds for producing female hatchling and methods of producing same

    WO2022224244A1